Kenneth Bryan Dart's Net Worth

Estimate Recalculated May 31, 2025 01:59AM EST

Who is Kenneth Bryan Dart

Kenneth Bryan Dart does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Deerfield Triarc Capital Corp, AASTROM BIOSCIENCES INC, PEREGRINE PHARMACEUTICALS INC, Cyclacel Pharmaceuticals, Inc., iBio, Inc., TAPIMMUNE INC, and CYTOKINETICS INC.

SEC CIK

Kenneth Bryan Dart's CIK is 0001331271

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AASTROM BIOSCIENCES INC

Investor

Updated Jul 11, 2014

View Quote Details


Form 4	—	—	$4.80	$1.74M	Jul 11, 2014	787.49K	Options	—	Jul 09
Form 3	—	—	—	—	Aug 23, 2013	8.50M	—	—	—

Showing 2 results

PEREGRINE PHARMACEUTICALS INC

Investor

Updated Sep 29, 2017

View Quote Details


Form 4	—	—	—	—	Sep 29, 2017	4.22M	—	—	—
Form 3	—	—	—	—	Nov 02, 2015	26.44M	—	—	—

Showing 2 results

Cyclacel Pharmaceuticals, Inc.

Investor

Updated May 05, 2020

View Quote Details


Form 4	—	—	—	—	May 05, 2020	65.86K	—	—	—
Form 4	64.53%	850.00K	$2.00	$1.70M	Jul 21, 2017	2.17M	Purchase	—	Jul 19
Form 3	—	—	—	—	Mar 17, 2015	5.61M	—	—	—

Showing 3 results

iBio, Inc.

Investor

Updated Aug 11, 2020

View Quote Details


Form 4	105.70%	4.43M	$1.74	-$74.16M	Aug 11, 2020	8.63M	Sell-Options	—	Aug 07 - Aug 11
Form 4	-11.42%	-4.27M	$4.27	-$18.22M	Aug 06, 2020	33.11M	Sale	—	Aug 04 - Aug 06
Form 4/A	—	1.00	—	—	Jan 31, 2020	1.00	Acq/Dis	—	Mar 14
Form 4	—	1.00	—	—	Mar 15, 2019	1.00	Acq/Dis	—	Mar 14
Form 4	-50.00%	-1.00	—	—	Jan 03, 2019	1.00	Disposition	—	Jan 01
Form 4	35.16%	2.20M	$0.90	$1.98M	Jul 13, 2018	8.46M	Purchase	—	Jul 12
Form 4	36.93%	1.69M	$500.45	$7.30M	Jun 28, 2018	6.26M	Purchase	—	Jun 26
Form 4	35.56%	12.00M	$0.20	$2.40M	Dec 04, 2017	45.74M	Purchase	—	Nov 30
Form 4	—	1.00	—	—	Feb 27, 2017	1.00	Purchase	—	Feb 23
Form 4	23.86%	6.50M	$0.62	$4.04M	Apr 11, 2016	33.74M	Purchase	—	Apr 07
Form 4	14.74%	3.50M	$0.59	$3.12M	Jan 27, 2016	27.24M	Purchase	—	Jan 25
Form 4/A	—	—	$0.40	—	Oct 17, 2013	21.96M	Options	—	Oct 15
Form 4	62.44%	6.24M	—	—	Apr 30, 2013	16.24M	Purchase	—	Apr 26
Form 3	—	—	—	—	Jan 19, 2012	10.00M	—	—	—

Showing 14 results

Marker Therapeutics, Inc.

Investor

Updated Nov 13, 2020

View Quote Details


Form 4	—	—	—	—	Nov 13, 2020	4.05M	—	—	—
Form 4	-100.00%	-416.67K	—	—	Jun 19, 2020	—	Disposition	—	Jun 16
Form 4	—	—	$1.20	$500.00K	Feb 20, 2020	4.05M	Options	—	Feb 18
Form 4	32.50%	1.30M	$2.40	$3.12M	May 16, 2018	5.30M	Purchase	—	May 14
Form 4	40.00%	8.00M	$0.50	—	Aug 12, 2016	28.00M	Options	—	Aug 10
Form 4	—	—	$0.20	$2.00M	Sep 11, 2015	20.00M	Options	—	Sep 09
Form 4	—	—	$0.50	$2.50M	Jun 18, 2015	10.00M	Options	—	Jun 16
Form 4	—	10.00M	—	—	Jun 01, 2015	5.00M	Acq/Dis	—	May 28
Form 3	—	—	—	—	Mar 17, 2015	5.00M	—	—	—

Showing 9 results

Deerfield Triarc Capital Corp

Investor

Updated Mar 14, 2006


Form 4/A	19.74%	30.00K	$12.95	$388.43K	Mar 14, 2006	182.00K	Purchase	—	Mar 13
Form 3	—	—	—	—	Jun 28, 2005	10.00M	—	—	—

Showing 2 results

CYTOKINETICS INC

Investor

Updated Feb 27, 2014

View Quote Details


Form 4	20.97%	500.00K	$8.00	$4.00M	Feb 27, 2014	2.88M	Purchase	—	Feb 25

Showing 1 results